These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37196368)

  • 21. Development of a Simple
    Lu G; Zhang X; Zheng W; Sun J; Hua L; Xu L; Chu XJ; Ding S; Xiong W
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach.
    Singh R; Bhardwaj VK; Purohit R
    Comput Biol Med; 2021 Dec; 139():104965. PubMed ID: 34717229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with synthetic/designer unnatural nucleoside analogs: an in silico study.
    Bag SS; Sinha S; Dutta S; Baishya HJ; Paul S
    J Mol Model; 2023 Nov; 29(12):366. PubMed ID: 37950101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase.
    Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S
    Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
    Dhankhar P; Dalal V; Kumar V
    J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
    Wakchaure PD; Ghosh S; Ganguly B
    J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of Novel SARS-CoV-2 Inhibitors by Combination of Machine Learning and Molecular Modeling Methods.
    Güner E; Özkan Ö; Yalcin-Ozkat G; Ölgen S
    Med Chem; 2024; 20(2):153-231. PubMed ID: 37957860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RETRACTED ARTICLE: Discovery of (
    Rabie AM
    Chem Zvesti; 2021; 75(9):4669-4685. PubMed ID: 34025012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.
    Wang Y; Li P; Rajpoot S; Saqib U; Yu P; Li Y; Li Y; Ma Z; Baig MS; Pan Q
    Sci Rep; 2021 Dec; 11(1):23465. PubMed ID: 34873274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
    Zhao Z; Bourne PE
    J Proteome Res; 2020 Nov; 19(11):4698-4705. PubMed ID: 32946692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase.
    Pourfarjam Y; Ma Z; Kim IK
    Biochem Biophys Res Commun; 2022 Oct; 625():53-59. PubMed ID: 35947915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2.
    Mishra A; Rathore AS
    J Biomol Struct Dyn; 2022 Aug; 40(13):6039-6051. PubMed ID: 33491569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding.
    Alamri MA; Tahir Ul Qamar M; Alabbas AB; Alqahtani SM; Alossaimi MA; Azam S; Hashmi MH; Rajoka MSR
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic.
    Comunale BA; Larson RJ; Jackson-Ward E; Singh A; Koback FL; Engineer LD
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.
    Elfiky AA
    Life Sci; 2020 Jul; 253():117592. PubMed ID: 32222463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico.
    Elfiky AA; Azzam EB; Shafaa MW
    Mol Divers; 2022 Feb; 26(1):171-181. PubMed ID: 33389441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks.
    Zhang WF; Stephen P; Thériault JF; Wang R; Lin SX
    J Phys Chem Lett; 2020 Jun; 11(11):4430-4435. PubMed ID: 32392072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
    Marlin R; Desjardins D; Contreras V; Lingas G; Solas C; Roques P; Naninck T; Pascal Q; Behillil S; Maisonnasse P; Lemaitre J; Kahlaoui N; Delache B; Pizzorno A; Nougairede A; Ludot C; Terrier O; Dereuddre-Bosquet N; Relouzat F; Chapon C; Ho Tsong Fang R; van der Werf S; Rosa Calatrava M; Malvy D; de Lamballerie X; Guedj J; Le Grand R
    Nat Commun; 2022 Aug; 13(1):5108. PubMed ID: 36042198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein-protein interaction of RdRp with its co-factor NSP8 and NSP7 to decipher the interface hotspot residues for drug targeting: A comparison between SARS-CoV-2 and SARS-CoV.
    Sarma H; Jamir E; Sastry GN
    J Mol Struct; 2022 Jun; 1257():132602. PubMed ID: 35153334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.